Minors will be unable to receive puberty blockers, hormone therapies, and gender transition surgeries under a new ban from Florida’s Board of Medicine and Board of Osteopathic Medicine. The Board of Osteopathic Medicine allowed an exemption from the ban for those who are currently involved in an FDA Institutional Review Board program clinical trial.
From The Washington Examiner:
The Board of Medicine first began the process of drafting the rule in August following a request from state Surgeon General Joseph Ladapo to devise rules to block medical professionals from providing such treatments for youth. Last week, members of Florida's Board of Medicine and Board of Osteopathic Medicine Joint Rules/Legislative Committee recommended the rule during a meeting last week after hearing from members of the public testifying for and against it. The rule is the latest move under Florida Gov. Ron DeSantis's administration regarding transgender issues. Earlier this year, the Florida Agency for Health Care Administration, which runs the state Medicaid program, finalized a ruling barring the medical assistance program for low-income people from covering similar treatments, including puberty blockers, hormone therapy, and gender transition surgery.
